Capricor Therapeutics
CAPR
$4.64
Share price
-3.13%
Change (1 day)
-5.69%
Change (1 year)
Categories
Capricor Therapeutics (CAPR) - Cash on Hand
Cash on Hand as of March 2024 : $39.91 M
According to Capricor Therapeutics
's latest financial reports the company has $39.91 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Capricor Therapeutics - Cash on Hand chart (from 2001 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $39.48 M | -4.67% |
| 2022-12-31 | $41.42 M | 18.74% |
| 2021-12-31 | $34.88 M | 6.79% |
| 2020-12-31 | $32.66 M | 230.45% |
| 2019-12-31 | $9.88 M | 36.23% |
| 2018-12-31 | $7.25 M | -48.63% |
| 2017-12-31 | $14.12 M | -12.78% |
| 2016-12-31 | $16.19 M | 19.37% |
| 2015-12-31 | $13.56 M | 68.86% |
| 2014-12-31 | $8.03 M | 290.79% |
| 2013-12-31 | $2.05 M | -52.87% |
| 2012-12-31 | $4.36 M | 319.83% |
| 2011-12-31 | $1.03 M | -69.24% |
| 2010-12-31 | $3.37 M | 6.37% |
| 2009-12-31 | $3.17 M | -42.27% |
| 2008-12-31 | $5.5 M | -66.11% |
| 2007-12-31 | $16.23 M | |
| 2005-12-31 | $0 M | -55.75% |
| 2004-12-31 | $0 M | -41.15% |
| 2003-12-31 | $0 M | 4216% |
| 2002-12-31 | $0 M | -83.97% |
| 2001-12-31 | $0 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 65,581.12% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $1.21 B | 2,932.79% | 🇺🇸 USA |
 Cytokinetics
CYTK | $0.61 B | 1,450.62% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.82 B | 1,963.89% | 🇺🇸 USA |
 Palatin Technologies PTN | $10.01 M | -74.91% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $5.11 M | -87.18% | 🇺🇸 USA |